LeonaBio (LONA) Cash from Operations (2019 - 2026)
LeonaBio (LONA) reported Cash from Operations of 20903000.0 for Q1 2026, down 42.54% year-over-year from 36376230.57 in Q1 2025, and down 7.76% quarter-over-quarter from 19397000.0 in Q4 2025.
LeonaBio (LONA) Cash from Operations (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Cash from Operations data on file, last reported at 20903000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 20903000.0, down 42.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 51967000.0 (up 39.6% YoY), and the FY2025 annual result was 45729000.0, up 52.94% from the prior year.
- Cash from Operations declined to 20903000.0 in Q1 2026 per LONA's latest filing, from 19397000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 4668000.0 in Q3 2025 and troughed at 26293000.0 in Q4 2023.
- A 5-year average of 19824941.18 and a median of 21640000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 154.07% in 2022, then soared 79.72% in 2025.
- A 5-year view of Cash from Operations shows it stood at 15667000.0 in 2022, then slumped by 67.82% to 26293000.0 in 2023, then increased by 1.06% to 26013000.0 in 2024, then rose by 25.43% to 19397000.0 in 2025, then decreased by 7.76% to 20903000.0 in 2026.
- Business Quant data shows LONA's Cash from Operations at 20903000.0 in Q1 2026, 19397000.0 in Q4 2025, and 4668000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -20.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.90 Mn |
| Mar 31, 2026 | -20.90 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |